These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31239156)

  • 21. A comparison of oncological outcomes between transoral surgical and non-surgical treatment protocols in the management of oropharyngeal squamous cell carcinoma.
    Kao SS; Micklem J; Ofo E; Edwards S; Dhatrak D; Foreman A; Krishnan S; Hodge JC
    J Laryngol Otol; 2018 Apr; 132(4):349-355. PubMed ID: 28480836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
    Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
    Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
    Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
    Parhar HS; Weinstein GS; O'Malley BW; Shimunov D; Rassekh CH; Chalian AA; Newman JG; Basu D; Cannady SB; Rajasekaran K; Lin A; Lukens JN; Swisher-McClure S; Cohen RB; Bauml JM; Aggrawal C; Brody RM
    Head Neck; 2021 Oct; 43(10):2923-2934. PubMed ID: 34101290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Patient Perspective: Evaluating the Accessibility of Transoral Robotic Surgery Online Resources.
    Xing MH; Chai RL
    Ann Otol Rhinol Laryngol; 2022 Jan; 131(1):27-38. PubMed ID: 33843290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transoral robotic surgery for oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Mahmoud O; Sung K; Civantos FJ; Thomas GR; Samuels MA
    Head Neck; 2018 Apr; 40(4):710-721. PubMed ID: 29244238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes.
    Moore EJ; Van Abel KM; Price DL; Lohse CM; Olsen KD; Jackson RS; Martin EJ
    Head Neck; 2018 Apr; 40(4):747-755. PubMed ID: 29327784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx.
    Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U
    Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
    de Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J
    JAMA Otolaryngol Head Neck Surg; 2024 Jun; 150(6):463-471. PubMed ID: 38602692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
    Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
    Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
    Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary outcomes of neoadjuvant chemoimmunotherapy combined with transoral robotic surgery for locally advanced oropharyngeal squamous cell carcinoma].
    Chen RH; Liang FY; Han P; Lin PL; Lin XJ; Wang JY; Kong XW; Huang XM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):329-334. PubMed ID: 38599642
    [No Abstract]   [Full Text] [Related]  

  • 35. Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes.
    Troob S; Givi B; Hodgson M; Mowery A; Gross ND; Andersen PE; Clayburgh D
    Head Neck; 2017 Oct; 39(10):1969-1975. PubMed ID: 28758272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trans-oral robotic surgery for the management of oropharyngeal carcinomas: a 9-year institutional experience.
    Meccariello G; Montevecchi F; D'Agostino G; Iannella G; Calpona S; Parisi E; Costantini M; Cammaroto G; Gobbi R; Firinu E; Sgarzani R; Nestola D; Bellini C; De Vito A; Amadori E; Vicini C
    Acta Otorhinolaryngol Ital; 2019 Apr; 39(2):75-83. PubMed ID: 31097824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of HPV-Negative Oropharyngeal Cancer Treated With Transoral Robotic Surgery.
    Jackson RS; Stepan K; Bollig C; Sharma RK; Patel M; Massa S; Puram SV; Zevallos JP; Pipkorn P; Zenga J
    Otolaryngol Head Neck Surg; 2021 Nov; 165(5):682-689. PubMed ID: 33752484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upfront transoral robotic surgery (TORS)
    Zorzi SF; Agostini G; Chu F; Tagliabue M; Pietrobon G; Corrao G; Volpe S; Marvaso G; Colombo F; Cossu Rocca M; Gandini S; Gaeta A; Ruju F; Alterio D; Ansarin M
    Acta Otorhinolaryngol Ital; 2022 Aug; 42(4):334-347. PubMed ID: 35938555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of transoral robotic surgery: a preliminary clinical experience.
    Hurtuk A; Agrawal A; Old M; Teknos TN; Ozer E
    Otolaryngol Head Neck Surg; 2011 Aug; 145(2):248-53. PubMed ID: 21810777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.